Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040
Anthony B. El-Khoueiry, Jörg Trojan, Tim Meyer, Thomas C. C. Yau, Ignacio Melero, Masatoshi Kudo and 12 more
- Rank
- 51 of 3,639
- Percentile
- top 1.5%
- Where
- Annals of Oncology, 2023
- Citations
- 70
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.